Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of Troriluzole in Generalized Anxiety Disorder
NCT03829241 is registered in ClinicalTrials.gov with Biohaven Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of Troriluzole in Generalized Anxiety Disorder
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 19, 2019
- Completion date
- May 8, 2020
- Enrollment
- 881 (actual)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.